Management of gastric polyps: an endoscopy-based approach.

The endoscopic finding of a gastric polyp and the histopathologic report that follows may leave clinicians with questions that have not been addressed in formal guidelines: do all polyps need to be excised, or can they just be sampled for biopsy? If so, which ones and how many should be sampled? What follow-up evaluation is needed, if any? This review relies on the existing literature and our collective experience to provide practical answers to these questions. Fundic gland polyps, now the most frequent gastric polyps in Western countries because of widespread use of proton pump inhibitors, and hyperplastic polyps, the second most common polyps notable for their association with gastritis and their low but important potential for harboring dysplastic or neoplastic foci, are discussed in greater detail. Adenomas have had their name changed to raised intraepithelial neoplasia and are decreasing in parallel with Helicobacter pylori infection; however, they do retain their importance as harbingers of gastric cancer, particularly in East Asia. Gastrointestinal stromal tumors have low incidence and no known associations, but their malignant potential is high; early diagnosis and proper management are crucial. Although rare and benign, inflammatory fibroid polyps need to recognized, particularly by pathologists, to avoid misdiagnosis. Gastric neuroendocrine tumors (carcinoids) are important because of their association with either atrophic gastritis or the multiple endocrine neoplasia syndromes; those that do not arise in these backgrounds have high malignant potential and require aggressive management. The review concludes with some practical suggestions on how to approach gastric polyps detected at endoscopy.

[1]  A. Nishio,et al.  Characteristic endosonographic features of gastric inflammatory fibroid polyps. , 2001, Endoscopy.

[2]  M. Stolte Hyperplastic polyps of the stomach: associations with histologic patterns of gastritis and gastric atrophy. , 2001, The American journal of surgical pathology.

[3]  G. Qvigstad,et al.  Serum gastrin and chromogranin A levels in patients with fundic gland polyps caused by long-term proton-pump inhibition , 2008, Scandinavian journal of gastroenterology.

[4]  R. Allibone,et al.  Multiple and recurrent inflammatory fibroid polyps in a Devon family ('Devon polyposis syndrome'): an update. , 1992, Gut.

[5]  L. Grimelius,et al.  Gastric Carcinoids: Biologic Behavior and Prognosis After Differentiated Treatment in Relation to Type , 2005, Annals of surgery.

[6]  T. Sakurazawa,et al.  Disappearance of Hyperplastic Polyps in the Stomach after Eradication of Helicobacter pylori , 1998, Annals of Internal Medicine.

[7]  M. Stolte,et al.  Frequency, Location, and Age and Sex Distribution of Various Types of Gastric Polyp , 1994, Endoscopy.

[8]  A. Spigelman,et al.  Upper gastrointestinal pathology in familial adenomatous polyposis: results from a prospective study of 102 patients. , 1990, Journal of clinical pathology.

[9]  J. Stoner,et al.  Multicenter Experience with Upper Gastrointestinal Polyps in Pediatric Patients with Familial Adenomatous Polyposis , 2004, American Journal of Gastroenterology.

[10]  M. Rugge,et al.  Gastric epithelial dysplasia. How clinicopathologic background relates to management , 1995, Cancer.

[11]  N. Ahmed,et al.  Fracture Risk and Bone Mineral Density Reduction Associated with Proton Pump Inhibitors , 2012, Pharmacotherapy.

[12]  K. Lapane,et al.  Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis , 2012, Alimentary pharmacology & therapeutics.

[13]  H. Chae,et al.  [Spontaneous resolution of multiple fundic gland polyps after cessation of treatment with omeprazole]. , 2008, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.

[14]  A. Zangrandi,et al.  Natural history, clinicopathologic classification and prognosis of gastric ECL cell tumors. , 1998, The Yale journal of biology and medicine.

[15]  R. Jensen,et al.  NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. , 2010, Pancreas.

[16]  Ming-Tsan Lin,et al.  Gastric outlet obstruction due to giant hyperplastic gastric polyps. , 2005, Journal of the Formosan Medical Association = Taiwan yi zhi.

[17]  T. Nakayama,et al.  Carcinoma in gastric hyperplastic polyps. A phenotypic study. , 1996, Digestive diseases and sciences.

[18]  M. Stolte,et al.  Gastric Carcinoids and Neuroendocrine Carcinomas: Pathogenesis, Pathology, and Behavior , 1996, World Journal of Surgery.

[19]  K. Okazaki,et al.  Atypical EUS features of gastric inflammatory fibroid polyps. , 2005, Gastrointestinal endoscopy.

[20]  M. Rugge,et al.  The long term outcome of gastric non-invasive neoplasia , 2003, Gut.

[21]  D. Graham,et al.  Gastritis staging in clinical practice: the OLGA staging system , 2006, Gut.

[22]  S. Jensen,et al.  The clopidogrel-PPI interaction: an updated mini-review. , 2012, Current vascular pharmacology.

[23]  E. G. Hahn,et al.  Diagnostic accuracy of forceps biopsy versus polypectomy for gastric polyps: a prospective multicentre study , 2002, Gut.

[24]  H. Mitomi,et al.  p53, but not c-Ki-ras, mutation and down-regulation of p21WAF1/CIP1 and cyclin D1 are associated with malignant transformation in gastric hyperplastic polyps. , 2001, American journal of clinical pathology.

[25]  B. Rovner,et al.  Randomized clinical trial: a pilot study investigating the safety and effectiveness of an escalating dose of peginterferon &agr;-2a monotherapy for 48 weeks compared with standard clinical care in patients with hepatitis C cirrhosis , 2012, European journal of gastroenterology & hepatology.

[26]  M. Stolte,et al.  Why is the hyperplastic polyp a marker for the precancerous condition of the gastric mucosa? , 2005, Virchows Archiv.

[27]  R. Genta,et al.  Reactive gastropathy is associated with inflammatory conditions throughout the gastrointestinal tract , 2012, Alimentary pharmacology & therapeutics.

[28]  J. Lasota,et al.  Gastrointestinal stromal tumors – definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis , 2000, Virchows Archiv.

[29]  P. Sipponen,et al.  Gastric polyps; their morphological and endoscopical characteristics and relation to gastric carcinoma. , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology.

[30]  R. DeMatteo,et al.  Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. , 2000, Annals of surgery.

[31]  C. O'Morain,et al.  Review article: the long‐term use of proton‐pump inhibitors , 2005, Alimentary pharmacology & therapeutics.

[32]  A. D. Van den Abbeele,et al.  NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines. , 2007, Journal of the National Comprehensive Cancer Network : JNCCN.

[33]  R. Seruca,et al.  Microsatellite instability in hyperplastic and adenomatous polyps of the stomach , 1999, Cancer.

[34]  Tomoyuki Shibata,et al.  Correlation between magnifying narrow band imaging and histopathology in gastric protruding/or polypoid lesions: a pilot feasibility trial , 2012, BMC Gastroenterology.

[35]  Robert M. Genta,et al.  Management of gastric polyps: a pathology-based guide for gastroenterologists , 2009, Nature Reviews Gastroenterology &Hepatology.

[36]  Laura K. Bianchi,et al.  Fundic gland polyp dysplasia is common in familial adenomatous polyposis. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[37]  L. Pantanowitz,et al.  Inflammatory Fibroid Polyps of the Gastrointestinal Tract: Evidence for a Dendritic Cell Origin , 2004, The American journal of surgical pathology.

[38]  D. Lam-Himlin Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) , 2013 .

[39]  N. Vakil Prescribing Proton Pump Inhibitors , 2012, Drugs.

[40]  Erik C von Rosenvinge,et al.  Gastric masses in multiple endocrine neoplasia type I-associated Zollinger-Ellison syndrome. , 2009, Gastroenterology.

[41]  T. Nakajima,et al.  High incidence of microscopic gastrointestinal stromal tumors in the stomach. , 2006, Human pathology.

[42]  G. Qvigstad,et al.  Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A , 2012, Alimentary pharmacology & therapeutics.

[43]  M. P. Leòn,et al.  Dysplastic changes in gastric fundic gland polyps of patients with familial adenomatous polyposis. , 1999, Italian journal of gastroenterology and hepatology.

[44]  J. Misdraji,et al.  Reply , 1991, Gut.

[45]  Amitabh Srivastava,et al.  Gastric preneoplastic lesions and epithelial dysplasia. , 2007, Gastroenterology clinics of North America.

[46]  M. Saboorian,et al.  The Current Spectrum of Gastric Polyps: A 1-Year National Study of over 120,000 Patients , 2009, The American Journal of Gastroenterology.

[47]  A. Axon,et al.  Reflux gastritis: distinct histopathological entity? , 1986, Journal of clinical pathology.

[48]  B. Nilsson,et al.  Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST) , 2007, British Journal of Cancer.

[49]  G. Nakano,et al.  Histopathological classification and malignant change in gastric polyps. , 1985, Journal of clinical pathology.

[50]  H. Mischinger,et al.  Pyloric obstruction caused by prolapse of a hyperplastic gastric polyp. , 2002, Hepato-Gastroenterology.

[51]  L. Villani,et al.  Session 5: Morphology and Pathogenesis of Endocrine Hyperplasias, Precarcinoid Lesions, and Carcinoids Arising in Chronic Atrophic Gastritis , 1991 .

[52]  R. Schulick,et al.  Management of gastrointestinal stromal tumors. , 2008, The Surgical clinics of North America.

[53]  Christopher B. Tan,et al.  Gastrointestinal Stromal Tumors: A Review of Case Reports, Diagnosis, Treatment, and Future Directions , 2012, ISRN gastroenterology.

[54]  T. Sano,et al.  CD34 expression by inflammatory fibroid polyps of the stomach. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[55]  D. Graham,et al.  Fundic gland polyps developing during omeprazole therapy. , 1997, The American journal of gastroenterology.

[56]  A. Nasierowska-Guttmejer [Neuroendocrine neoplasms of the stomach]. , 2013, Polish journal of pathology : official journal of the Polish Society of Pathologists.

[57]  J. Lasota,et al.  Gastrointestinal stromal tumors: pathology and prognosis at different sites. , 2006, Seminars in diagnostic pathology.

[58]  R. Mårvik,et al.  Gastric carcinoids after long‐term use of a proton pump inhibitor , 2012, Alimentary pharmacology & therapeutics.

[59]  G. Klöppel,et al.  The Gastroenteropancreatic Neuroendocrine Cell System and Its Tumors: The WHO Classification , 2004, Annals of the New York Academy of Sciences.

[60]  M. Rugge,et al.  Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Interdisciplinary Group on Gastric Epithelial Dysplasia. , 1994, Gastroenterology.

[61]  T. Hattori Morphological range of hyperplastic polyps and carcinomas arising in hyperplastic polyps of the stomach. , 1985, Journal of clinical pathology.

[62]  O. Louthan Neuroendocrine neoplasms of the stomach. , 2013, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[63]  L. Villani,et al.  Morphology and pathogenesis of endocrine hyperplasias, precarcinoid lesions, and carcinoids arising in chronic atrophic gastritis. , 1991, Scandinavian journal of gastroenterology. Supplement.

[64]  M. Stolte,et al.  ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. , 1999, Gastroenterology.

[65]  J. Meyerhardt,et al.  A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors , 2011, Cancer Chemotherapy and Pharmacology.

[66]  J. Kupryjańczyk,et al.  Malignant transformation of gastric hyperplastic polyps. , 2002, American journal of clinical pathology.

[67]  E. Wardelmann,et al.  Inflammatory fibroid polyps harbour mutations in the platelet‐derived growth factor receptor alpha (PDGFRA) gene , 2008, The Journal of pathology.

[68]  S. Wahl,et al.  p53 expression in precancerous gastric lesions: an immunohistochemical study of PAb 1801 monoclonal antibody on adenomatous and hyperplastic gastric polyps. , 1993, The American journal of gastroenterology.

[69]  K. Okazaki,et al.  Endoscopic features of gastric inflammatory fibroid polyps. , 1996, The American journal of gastroenterology.

[70]  M. Hongo,et al.  Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan , 2010, Journal of Gastroenterology.

[71]  D. Graham,et al.  Helicobacter pylori diagnosis and management. , 2006, Gastroenterology clinics of North America.

[72]  M F Dixon,et al.  Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. , 1996, The American journal of surgical pathology.

[73]  C. Antonescu,et al.  Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial , 2009, The Lancet.

[74]  R. Genta,et al.  No association between gastric fundic gland polyps and gastrointestinal neoplasia in a study of over 100,000 patients. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[75]  N. Abraham Proton pump inhibitors: potential adverse effects , 2012, Current opinion in gastroenterology.

[76]  J. Lasota,et al.  Histopathology of gastrointestinal stromal tumor , 2011, Journal of surgical oncology.

[77]  K. Elster Histologic classification of gastric polyps. , 1976, Current topics in pathology. Ergebnisse der Pathologie.

[78]  E. Kuipers,et al.  The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. , 2010, Gastrointestinal endoscopy.

[79]  Tsung-Teh Wu,et al.  Genetic Alterations in Gastric Adenomas of Intestinal and Foveolar Phenotypes , 2003, Modern Pathology.

[80]  L. Anemona,et al.  Inflammatory fibroid polyp. A case report and review of the literature. , 2012, Annali italiani di chirurgia.

[81]  L. Poritz,et al.  PPI Therapy and Albumin are Better Predictors of Recurrent Clostridium difficile Colitis than Choice of Antibiotics , 2012, Journal of Gastrointestinal Surgery.

[82]  T. Viset,et al.  Gastric neuroendocrine carcinoma after long-term use of proton pump inhibitor , 2012, Scandinavian journal of gastroenterology.

[83]  D. Graham,et al.  Noninvasive versus histologic detection of gastric atrophy in a Hispanic population in North America. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[84]  P. Davaris,et al.  Gastric epithelial polyps: a retrospective endoscopic study of 12974 symptomatic patients. , 1996, The Italian journal of gastroenterology.